March 8, 2013in Access to Medicines, Competition, Human Rights, IP, Patent Practice, Patentability, Patents1by Editor234 The ‘Myriad’ with the Golden ‘Gene’: Australia Upholds Breast Cancer Gene Patents The Myriad Genetics gene patenting saga has officially shaped international jurisprudence, with the Federal Court of Australia upholding the patents for BRCA1 and BRCA2. In Cancer Voices Australia v. Myriad…
